A Phase II Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients with Refractory Gastrointestinal Stromal Tumor

Diseases and Conditions Researched

Cancer; Other Digestive Organ

What is the purpose of this trial?

To determine the progression-free survival (PFS) of patients with refractory GIST treated with AUY922.


Participation Guidelines

Age: 18 Years and older
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: Sarah Cannon Research Institute Oncology Research Consortium
Dates:
Last Updated:
Study HIC#: 1301011364